https://www.selleckchem.com/pr....oducts/pacritinib-sb
The trial has been approved by the Northern A Health and Disability Ethics Committee of New Zealand (17/NTA/233). Dissemination plans include publication in international peer-reviewed journals, and presentation at national and international scientific meetings, assimilation into national and international guidelines, and presentation of findings to lay audiences through established media links. ACTRN12618000303246; Pre-results. ACTRN12618000303246; Pre-results. To assess the contribution of a digital health real-time monitori
Like
Comment
Share
